Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_provenance.
- NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_assertion description "[Riboflavin is considered to be effective by activating the NADPH diaphorase (NADPH flavin reductase) system and appears to be useful for the treatment of congenital methaemoglobinaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_provenance.
- NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_assertion evidence source_evidence_literature NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_provenance.
- NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_assertion SIO_000772 6893937 NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_provenance.
- NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_assertion wasDerivedFrom befree-2016 NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_provenance.
- NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_assertion wasGeneratedBy ECO_0000203 NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1307213.RA6FiN6_qlPDb0k5JfO8w6YcCa7UePYvWnM0YycSPtTZU130_provenance.